Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumor heterogeneity
Christina S. Fjeldbo, Tord Hompland, Tiril Hillestad, Eva-Katrine Aarnes, Clara-Cecilie Günther, Gunnar B. Kristensen, Eirik Malinen, Heidi Lyng
doi: https://doi.org/10.1101/2020.05.28.20115386
Christina S. Fjeldbo
1Department of Radiation Biology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Tord Hompland
1Department of Radiation Biology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
2Department of Core Facilities, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Tiril Hillestad
2Department of Core Facilities, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Eva-Katrine Aarnes
1Department of Radiation Biology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Clara-Cecilie Günther
3Norwegian Computing Center, Oslo, Norway
Gunnar B. Kristensen
4Department of Gynaecologic Oncology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
5Institute for Cancer Genetics and Informatics, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Eirik Malinen
6Department of Medical Physics, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
7Department of Physics, University of Oslo, Oslo, Norway
Heidi Lyng
1Department of Radiation Biology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
7Department of Physics, University of Oslo, Oslo, Norway
Data Availability
The data have been deposited in the gene expression omnibus (GEO) database (GSE146114), which will be released upon publication.
Posted May 29, 2020.
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumor heterogeneity
Christina S. Fjeldbo, Tord Hompland, Tiril Hillestad, Eva-Katrine Aarnes, Clara-Cecilie Günther, Gunnar B. Kristensen, Eirik Malinen, Heidi Lyng
medRxiv 2020.05.28.20115386; doi: https://doi.org/10.1101/2020.05.28.20115386
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumor heterogeneity
Christina S. Fjeldbo, Tord Hompland, Tiril Hillestad, Eva-Katrine Aarnes, Clara-Cecilie Günther, Gunnar B. Kristensen, Eirik Malinen, Heidi Lyng
medRxiv 2020.05.28.20115386; doi: https://doi.org/10.1101/2020.05.28.20115386
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (205)
- Emergency Medicine (372)
- Epidemiology (11633)
- Forensic Medicine (10)
- Gastroenterology (685)
- Genetic and Genomic Medicine (3638)
- Geriatric Medicine (342)
- Health Economics (624)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3393)
- Nursing (193)
- Nutrition (512)
- Oncology (1783)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6031)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (144)